ArticleInternational journal of molecular sciences2024

O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy.

Wenkang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.